HDT Bio: Funding, Investors & Team (Oct 2026)
HDT Bio specializes in creating RNA vaccines and medications using LION formulation technology. Their advanced technology and products encompass various methods of immunotherapy, such as boosting the body's natural defenses, enhancing the adaptive immune response, and disrupting tumor-tight junctions. The company aims to continue advancing in the battle against deadly infectious diseases by developing innovative and affordable immunotherapy solutions accessible across global markets, including low-income and middle-income nations.
HDT Bio has raised $2.8M across 2 funding rounds on record, the most recent an undisclosed round of $1.0M announced in Oct 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
HDT Bio Company Profile and Key Stats
Latest funding round on record: Oct 2023.
HDT Bio Funding Rounds
HDT Bio raised $1.8M in a Grant announced in Aug 2022.
1.2 years later, an undisclosed round of $1.0M was announced in Oct 2023.
HDT Bio Founders and Leadership Team
Contact details for the HDT Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →HDT Bio Funding Compared to Other Biotechnology Startups
HDT Bio's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like HDT Bio in Biotechnology and Seattle
Companies Similar to HDT Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
HDT Bio Funding FAQs
What does HDT Bio do?
HDT Bio specializes in creating RNA vaccines and medications using LION formulation technology. Their advanced technology and products encompass various methods of immunotherapy, such as boosting the body's natural defenses, enhancing the adaptive immune response, and disrupting tumor-tight junctions. The company aims to continue advancing in the battle against deadly infectious diseases by developing innovative and affordable immunotherapy solutions accessible across global markets, including low-income and middle-income nations.
How much funding has HDT Bio raised?
HDT Bio has raised $2.8M across 2 rounds on record. The most recent is an undisclosed round of $1.0M announced in Oct 2023.
When did HDT Bio last raise funding?
HDT Bio's most recent funding round on record is an undisclosed round of $1.0M, announced in Oct 2023.
Who founded HDT Bio?
FundedIQ lists Christopher Pirie (Founder) at HDT Bio.
Where is HDT Bio headquartered?
HDT Bio is based in Seattle, Washington, United States.
How many employees does HDT Bio have?
HDT Bio is in the 11-50 employee band.
How does HDT Bio's funding compare to other Biotechnology startups?
HDT Bio's latest round of $1.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's HDT Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for HDT Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.